Research paperLipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid
References (31)
- et al.
Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis
Atherosclerosis
(1990) - et al.
Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment
Atherosclerosis
(1985) - et al.
Lipoprotein(a) reduction by N-acetylcysteine
Lancet
(1991) N-acetylcysteine and immunoreactivity of lipoprotein(a)
Lancet
(1991)- et al.
Fluctuations of plasma lipoprotein-(a) concentrations during pregnancy and post partum
Metabolism
(1986) - et al.
Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanazolol
Biochim. Biophys. Acta
(1984) - et al.
A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol
J. Lipid Res.
(1978) - et al.
Catabolism of lipoprotein (a) in familial hypercholesterolaemic subjects
Atherosclerosis
(1991) - et al.
Sex, plasma lipoproteins and atherosclerosis: prevailing assumptions and outstanding questions
Am. Heart J.
(1987) - et al.
Effects of high endogenous oestrogen level on lipoprotein concentrations
Atherosclerosis
(1990)
The mysteries of lipoprotein (a)
Science
(1989)
A new serum type system in man — the LP-system
Acta. Pathol. Microbiol. Scand.
(1963)
cDNA sequence of human apolipoprotein (a) is homologous to plasminogen
Nature
(1987)
Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid
J. Intern. Med.
(1989)
Metabolic effects of danazol
J. Int. Med. Res.
(1977)
Cited by (111)
Non-genetic influences on lipoprotein(a) concentrations
2022, AtherosclerosisAnabolic steroid excess and myocardial infarction: From ischemia to reperfusion injury
2020, SteroidsCitation Excerpt :Indeed, dyslipidemia was observed after three days of administration of stanozolol at 6 mg/day, while the effect on triglyceride lipase emerged after only one day of administration [34]. Over time, LDL/HDL can also be enhanced by AS effects on apolipoproteins (Apo) levels [30,33–35]. Circulating Apo-A1 and Apo-D, both components of HDL, have been shown to be down-regulated in AS users under the administration of nandrolone decanoate at 200 mg/wk for eight weeks [36].
Danazol - Options of usage for the treatment of haematological diseases
2014, Acta Haematologica PolonicaLipoprotein(A)
2009, Clinical Lipidology: A Companion to Braunwald's Heart DiseaseLipoprotein(a)
2008, Clinical Lipidology: A Companion to Braunwald's Heart Disease Expert Consult: Online and PrintLipoprotein(a): A Unique Risk Factor for Cardiovascular Disease
2006, Clinics in Laboratory Medicine
Copyright © 1992 Published by Elsevier Ltd.